Gymnemic acids inhibit sodium-dependent glucose transporter 1

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 25, 2014, Pages 5925-5931

  Wang, Yu ^a   Dawid, Corinna ^a   Kottra, Gabor ^a   Daniel, Hannelore ^a   Hofmann, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

diabetes; Gymnema sylvestre; gymnemic acid V; gymnemic acid XV; inhibitor; SGLT1

Indexed keywords

GLUCOSE; MEDICAL PROBLEMS; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; CELL MEMBRANES; SODIUM;

CHINESE TRADITIONAL MEDICINE; GYMNEMA SYLVESTRE; GYMNEMIC ACIDS; HIGH-AFFINITY INHIBITORS; INHIBITOR; INTESTINAL EPITHELIAL CELLS; SGLT1; XENOPUS LAEVIS OOCYTES; GASTROINTESTINAL TRACT;

SODIUM; GLUCOSE;

GLUCOSE; GYMNEMIC ACID; HERBACEOUS AGENT; SAPONIN; SODIUM GLUCOSE COTRANSPORTER 1; TRITERPENE;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG EFFECTS; GENETICS; GYMNEMA SYLVESTRE; HUMAN; MEDICINAL PLANT; METABOLISM; OOCYTE; TRANSPORT AT THE CELLULAR LEVEL; XENOPUS LAEVIS;

ANIMALS; BIOLOGICAL TRANSPORT; DRUGS, CHINESE HERBAL; GLUCOSE; GYMNEMA SYLVESTRE; HUMANS; OOCYTES; PLANTS, MEDICINAL; SAPONINS; SODIUM-GLUCOSE TRANSPORTER 1; TRITERPENES; XENOPUS LAEVIS;

GYMNEMA SYLVESTRE; XENOPUS LAEVIS;

EID: 84903265535     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf501766u     Document Type: Article

References (40)

1. World Health Organisation Department of Noncommunicable Disease Surveillance Definition. Diagnosis and Classification of Diabetes Mellitus and Its Complications; Geneva, Switzerland, 1999.
2. Wild, S.; Roglic, G.; Green, A.; Sicree, R.; King, H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 2004, 27 (5) 1047-1053
3. Rother, K. I. Diabetes treatment - bridging the divide N. Engl. J. Med. 2007, 356 (15) 1499-1501
4. Rendell, M. The role of sulphonylureas in the management of type 2 diabetes mellitus Drugs 2004, 64, 1339-1358
5. Norisada, N.; Masuzaki, H.; Fujimoto, M.; Inoue, G.; Hosoda, K.; Hayashi, T.; Watanabe, M.; Muraoka, S.; Yoneda, F.; Nakao, K. Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivatives, FPFS-410 Metabolism 2004, 53, 1532-1537
6. Gupta, D.; Ghosh, N. N.; Chandra, R. Synthesis and pharmacological evaluation of substituted 5-[4-[2-(6,7-dimethyl-1,2,3,4-tetrahydro-2-oxo-4 quinoxalinyl) ethoxy] phenyl] methylene] thiazolidine-2,4-dione derivatives as potent euglycemic and hypolipidemic agents Bioorg. Med. Chem. Lett. 2005, 15, 1019-1022
7. Inzucchi, S. E. Oral antihyperglycemic therapy for type 2 diabetes JAMA, J. Am. Med. Assoc. 2002, 287, 360-372
8. Buse, J. B.; Henry, R. R.; Han, J.; Kim, D. D.; Fineman, M. S.; Baron, A. D. Effects of exenatide (Exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes Diabetes Care 2004, 27, 2628-2635
9. Chao, E. C.; Henry, R. R. SGLT2 inhibition-a novel strategy for diabetes treatment Nat. Rev./Drug Discovery 2010, 9, 551-559
10. Wood, I. S.; Trayhurn, P. Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins Br. J. Nutr. 2003, 89, 3-9
11. Joost, H. G.; Bell, G. I.; West, J. D.; Birnbaum, M. J.; Charron, M. J.; Chen, Y.; Doege, H.; James, D. E.; Lodish, H. F.; Moley, K. H.; Moley, J. F.; Mueckler, M.; Rogers, S.; Schurmann, A.; Seino, S.; Thorens, B. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators Am. J. Physiol. Endocrinol. Metab. 2002, 282, E974-E976
12. Marette, A.; Richardson, J. M.; Ramlal, T.; Balon, T. W.; Vranic, M.; Pessin, J. E.; Klip, A. Abundance, localization, and insulininduced translocation of glucose transporters in red and white muscle Am. J. Physiol. 1992, 263, C443-C452
13. Guillam, M. T.; Hummler, E.; Schaerer, E.; Yeh, J. I.; Birnbaum, M. J.; Beermann, F.; Schmidt, A.; Deriaz, N.; Thorens, B.; Wu, J. Y. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2 Nat. Genet. 1997, 17, 327-330
14. Bady, I.; Marty, N.; Dallaporta, M.; Emery, M.; Gyger, J.; Tarussio, D.; Foretz, M.; Thorens, B. Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding Diabetes 2006, 55, 988-995
15. Wright, E. M.; Turk, E. M. The sodium/glucose cotransport family SLC5 Pfluegers Arch. 2004, 447, 510-518
16. Asano, T.; Ogihara, T.; Katagiri, H.; Sakoda, H.; Ono, H.; Midori, F.; Anai, M.; Kurihara, H.; Yasunobu, U. Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs Curr. Med. Chem. 2004, 11, 2717-2724
17. Halaby, M. J.; Hibma, J. C.; He, J.; Yang, D. Q. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells Cell Signal. 2008, 20 (8) 1555-1563
18. Mckee, F. W.; Hawkins, W. B. Phlorhizin glucosuria Physiol. Rev. 1945, 25, 255-280
19. Ehrenkranz, J. R. L.; Lewis, N. G.; Kahn, C. R.; Roth, J. Phlorizin: a review Diabetes Metab. Res. Rev. 2005, 21, 31-38
20. Abdul-Ghani, M. A.; Norton, L.; deFronzo, R. A. Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes Endocrine Rev. 2011, 32 (4) 515-531
21. +/glucose cotransporter (SGLT1) in the small intestine J. Controlled Release 2008, 125, 42-49
22. +/glucose transporter when expressed in xenopus laevis oocytes, but effectively inhibit electrogenic glucose uptake J. Pharmacol. Exp. Ther. 2007, 322, 829-835
23. Kobayashi, Y.; Suzuki, M.; Satsu, H.; Arai, S.; Hara, Y.; Suzuki, K.; Miyamoto, Y.; Shimizu, M. Green tea polyphenols inhibit the sodium-dependent glucose transporter of intestinal epithelial cells by a competitive mechanism J. Agric. Food Chem. 2000, 48, 5618-5623
24. Zhu, Y.-P. Chinese Materia Medica. Chemistry, Pharmacology and Applications; Harwood Academic Publisher: Amsterdam, The Netherlands, 1998; Vol. 29.
25. Wright, E. M. The intestine Na+/glucose cotransporter Annu. Rev. Physiol. 1993, 55, 575-589
26. Shanmugasundaram, K. R.; Panneerselvam, C.; Sumudram, P.; Shanmugasundaram, K. R. B. Enzym changes and glucose utilization in diabetic rabbits: the effect of Gymnema sylvestre, R.Br J. Ethnopharmacol. 1983, 7, 205-234
27. Shanmugasundaram, E. R. B.; Leela Gopinath, K.; Rhada Shanmugasundaram, K.; Rajendran, V. M. Possible regeneration of the islets of Langerhans in streptozotocin-diabetic rats given Gymnema sylvestre leaf extract J. Ethnopharmacol. 1990, 30, 265-279
28. Shanmugasundaram, E. R.; Rajeswari, G.; Baskaran, K.; Rajesh Kumar, B. R.; Radha Shanmugsundarama, K.; Kizar Ahmath, B. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus J. Ethnopharmacol. 1990, 30, 281-294
29. Shimizu, K.; Iino, A.; Nakajima, J.; Tanaka, K.; Nakajyo, S.; Urakawa, N.; Atsuchi, M.; Wada, T.; Yamashita, C. Supression of glucose absorption by some fractions extracted from Gymnema sylvestre leafs J. Vet. Med. Sci. 1997, 59 (4) 245-251
30. Persaud, S. J.; Al-Majed, H.; Raman, A.; Jones, P. M. Gymnema sylvestre stimulates insulin release in vitro by increased membrane permeability J. Endocrinol. 1999, 163, 207-212
31. Sugihara, Y.; Nojima, H.; Matsuda, H.; Murakami, T.; Yoshikawa, M.; Kimura, I. Antihyperglycemic effects of gymnemic acid IV, a compound derived from Gymnema sylvestre leaves in streptocin-diabetic mice J. Asian Nat. Prod. Res. 2000, 2, 321-327
32. Kenetkar, P.; Singhal, R.; Kamat, M. Gymnema sylvestre: a memoir J. Clin. Biochem. Nutr. 2007, 41, 77-81
33. 2) Chem. Pharm. Bull. 1993, 41 (10) 1730-1732
34. Liu, H.; Kiuchi, F.; Tsuda, Y. Isolation and structure elucidation of gymnemic acids, antisweet principles of Gymnema sylvestre Chem. Pharm. Bull. 1992, 40 (6) 1366-1375
35. Mahato, S. B. Bioactive gymnemic acids and congeners from Gymnema sylvestre. In Studies in Natural Product Chemistry; Atta-ur-Rhaman, Ed.; Elsevier Science: Amsterdam, The Netherlands, 1996; Vol. 18, pp 649-676.
36. Murakami, N.; Murakami, T.; Kadoya, M.; Matsuda, H.; Yamahara, J.; Yoshikawa, M. New hypoglycemic constituents in "gymnemic acid" from Gymnema sylvestre Chem. Pharm. Bull. 1996, 44 (2) 469-471
37. Pajor, A. M.; Randolph, K. M.; Kerner, S. A.; Smith, C. D. Inhibitor binding in the human renal low- and high-affinity Na/glucose cotransporters J. Pharmacol. Exp. Ther. 2008, 324, 985-991
38. Chang, H.-C.; Yang, F.-F.; Huang, Ch.-Ch.; Lin, T.-S.; Liang, P.-H.; Lin, Ch.-J.; Lih-Ching Hsu, L.-Ch. Development of a novel non-radioactive cell-based method for the screening of SGLT1 and SGLT2 inhibitors using 1-NBDG Mol. BioSyst. 2013, 9, 2010-2020
39. Castaneda, F.; Burse, A.; Boland, W.; Kinne, R. K.-H. Thioglycosides as inhibitors of hSGLT1 and hSGLT2: potential therapeutic agents for the control of hyperglycemia in diabetes Int. J. Med. Sci. 2007, 4, 131-139
40. 1) The inhibitors of glucose absorption from the leaves of Gymnema sylvestre R. Br. (Asclepiadaceae): structures of gymnemosides a and b Chem. Pharm. Bull. 1997, 45 (10) 1671-1676